Tenaya Therapeutics Inc. (TNYA)
NASDAQ: TNYA
· Real-Time Price · USD
1.16
0.21 (22.51%)
At close: Aug 15, 2025, 3:59 PM
1.16
-0.01%
After-hours: Aug 15, 2025, 06:47 PM EDT
Tenaya Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 17.66M | 17.66M | 17.66M | 17.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.08M | 2.12M | 4.28M | 7.26M | 10.24M | 11.09M | 11.82M | 11.69M | 11.51M | 10.3M | 8.71M | 6.97M | 5.22M | 4.46M | 3.85M | 2.74M | 1.69M | 689K |
Gross Profit | -2.08M | -2.12M | -4.28M | 10.4M | 7.42M | 6.57M | 5.84M | -11.69M | -11.51M | -10.3M | -8.71M | -6.97M | -5.22M | -4.46M | -3.85M | -2.74M | -1.69M | -689K |
Operating Income | -102.98M | -109.72M | -115.95M | -122.74M | -126.95M | -131.23M | -131.19M | -134.3M | -134.68M | -128.19M | -125.62M | -117.23M | -104.24M | -90.86M | -72.81M | -56.96M | -49.12M | -42.75M |
Interest Income | 3.34M | 3.92M | 4.74M | 5.39M | 6.09M | 6.54M | 7.06M | 6.62M | 5.44M | 3.83M | 1.95M | 984K | 411K | 198K | 108K | 46K | 30K | 39K |
Pretax Income | -99.62M | -105.77M | -111.13M | -117.23M | -120.74M | -124.58M | -124.08M | -127.67M | -129.22M | -124.35M | -123.67M | -116.3M | -103.87M | -90.68M | -72.72M | -56.89M | -48.92M | -42.44M |
Net Income | -99.62M | -105.77M | -111.13M | -117.23M | -120.74M | -124.58M | -124.08M | -128.59M | -129.54M | -124.44M | -123.66M | -115.38M | -103.55M | -90.58M | -72.72M | -56.89M | -48.92M | -42.44M |
Selling & General & Admin | 23.41M | 24.84M | 24.93M | 24.56M | 23.05M | 22.65M | 21.34M | 24.54M | 27.23M | 29.32M | 31.08M | 27.49M | 25.31M | 21.9M | 18.41M | 15.16M | 11.78M | 9.36M |
Research & Development | 77.48M | 82.76M | 86.74M | 90.92M | 93.66M | 97.49M | 98.04M | 100.92M | 101.59M | 95.99M | 94.54M | 89.74M | 78.93M | 68.96M | 54.39M | 41.8M | 37.34M | 33.39M |
Other Expenses | n/a | -1K | 81K | 122K | 123K | 122K | 53K | 9K | 14K | 16K | 2K | -49K | -40K | -22K | -23K | 30K | 15K | -3K |
Operating Expenses | 100.9M | 107.6M | 111.67M | 115.48M | 116.71M | 120.14M | 119.37M | 125.47M | 128.82M | 125.31M | 125.62M | 117.23M | 104.24M | 90.86M | 72.81M | 56.96M | 49.12M | 42.75M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5K | 5K | 5K |
Selling & Marketing Expenses | n/a | -2.12M | -4.28M | -7.26M | -10.24M | -11.09M | -11.82M | -8.83M | -5.86M | -2.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 102.98M | 109.72M | 115.95M | 122.74M | 126.95M | 131.23M | 131.19M | 134.3M | 134.68M | 128.19M | 125.62M | 117.23M | 104.24M | 90.86M | 72.81M | 56.96M | 49.12M | 42.75M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 920.04K | 318.04K | 96.04K | -1.96K | -922K | -358K | -172K | -81K | -90K | -52K | -16K |
Shares Outstanding (Basic) | 162.79M | 109.87M | 86.41M | 86.16M | 85.71M | 80.98M | 68.33M | 73.92M | 73.4M | 73.1M | 55.25M | 41.36M | 41.3M | 41.27M | 41.25M | 26.9M | 37.32M | 27.2M |
Shares Outstanding (Diluted) | 162.79M | 109.87M | 86.41M | 86.16M | 85.71M | 80.98M | 68.33M | 73.92M | 73.4M | 73.1M | 55.25M | 41.36M | 41.3M | 41.27M | 41.25M | 26.9M | 37.32M | 27.2M |
EPS (Basic) | -0.96 | -1.16 | -1.32 | -1.48 | -1.57 | -1.68 | -1.71 | -1.89 | -2.23 | -2.46 | -2.78 | -2.79 | -2.74 | -2.47 | -2.2 | -1.95 | -1.65 | -1.56 |
EPS (Diluted) | -0.96 | -1.16 | -1.32 | -1.48 | -1.57 | -1.68 | -1.71 | -1.89 | -2.23 | -2.46 | -2.78 | -2.79 | -2.74 | -2.47 | -2.2 | -1.95 | -1.65 | -1.56 |
EBITDA | -93.25M | -100.75M | -107.48M | -114.18M | -118.31M | -122.52M | -122.51M | -125.67M | -126.15M | -120.56M | -119.15M | -111.76M | -100.1M | -87.28M | -69.51M | -54.14M | -46.4M | -40.16M |
EBIT | -101.51M | -109.05M | -115.95M | -122.74M | -126.95M | -131.23M | -131.19M | -134.3M | -134.68M | -128.19M | -125.62M | -117.23M | -104.24M | -90.86M | -72.81M | -56.96M | -49.12M | -42.75M |
Depreciation & Amortization | 8.94M | 8.97M | 8.47M | 9.37M | 10.24M | 11.09M | 11.82M | 11.69M | 11.51M | 10.3M | 8.71M | 6.97M | 5.22M | 4.46M | 3.85M | 3.4M | 2.98M | 2.59M |